A phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
American Journal of Clinical Oncology: Cancer Clinical Trials.
Times cited: 10
Phase II trial of uracil and tegafur plus oral leucovorin: An effective oral regimen in the treatment of metastatic colorectal carcinoma.
Journal of Clinical Oncology.
Times cited: 221